C4 Therapeutics, Inc. Profile Avatar - Palmy Investing

C4 Therapeutics, Inc.

C4 Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel therapeutic candidates to degrade disease-causing proteins for the treatment of cancer, neurodegenerative conditions, and other diseases. Its lead product candidate is CFT7…

Biotechnology
US, Watertown [HQ]

Document Reader

Click To Read:

DEF 14-A Proxies

Not a single DEF 14-A proxy doc.

10-K Filings

Not a single 10-K doc.

10-Q Filings

Not a single 10-Q doc.

LDA 1/2 Filings [Lobbying]

Not a single LDA doc.

End of CCCC's Analysis
CIK: 1662579 CUSIP: 12529R107 ISIN: US12529R1077 LEI: - UEI: -
Secondary Listings
CCCC has no secondary listings inside our databases.